FIELD: medicine.
SUBSTANCE: invention relates to medicine, specifically to pharmacology, and deals with neurogenesis stimulation in ischemic cerebral injuries. To this end p-thyrosol is added in an effective amount.
EFFECT: this provides stimulation of neurogenesis and recovery of initial level of neurons in hippocampus under conditions of complete cerebral ischemia in experimental animals.
1 cl, 4 ex, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
AGENT POSSESSING ENDOTHELIUM PROTECTIVE ACTIVITY | 2014 |
|
RU2563622C1 |
MEANS IMPROVING MICROVASCULARIZATION IN BRAIN TISSUE | 2017 |
|
RU2650624C1 |
ANTI-ISCHEMIC DRUG | 2012 |
|
RU2499593C1 |
AGENT FOR RELIEVING POSTINFARCTION MYOCARDIAL REMODELING | 2022 |
|
RU2830221C2 |
ANTIISHEMIC AGENT | 2008 |
|
RU2384327C1 |
METHOD FOR PREVENTION OF BRAIN ISCHEMIA | 2017 |
|
RU2642961C1 |
ACTIVE DRUG INGREDIENT, DRUG, PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT OF DEMYELINATING DISEASES OF LIVING ORGANISM, INCLUDING DISEASE PREVENTION | 2015 |
|
RU2631887C2 |
METHOD FOR PREVENTING CEREBRAL ISCHEMIA | 2018 |
|
RU2696203C1 |
AGENT POSSESSING NEUROPROTECTIVE ACTIVITY | 2018 |
|
RU2701739C1 |
METHOD FOR TREATMENT OF NEUROPATHIC PAIN | 2021 |
|
RU2780139C1 |
Authors
Dates
2016-05-27—Published
2015-06-30—Filed